These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

106 related items for PubMed ID: 3888116

  • 1. [Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
    Masaoka T, Kimura K, Miyazaki T, Hirota Y, Nakamura T, Yasunaga K, Ohkubo H, Okamoto Y, Fujitake H, Kitani T.
    Gan To Kagaku Ryoho; 1985 May; 12(5):1111-8. PubMed ID: 3888116
    [Abstract] [Full Text] [Related]

  • 2. A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
    Hiraoka A, Masaoka T, Shibata H, Miyazaki T, Nakamura T, Yasunaga K, Kitani T, Yonezawa T, Kawagoe H, Horiuchi A.
    Leuk Res; 1988 May; 12(6):487-90. PubMed ID: 3043111
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prolonged remission in a patient with chronic myelocytic leukemia (CML) by methyl 6-[3-(2-chloroethyl)-3-deoxy-alpha-D-glucopyranoside (MCNU)].
    Murase T, Nagura E, Ohno R.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2590-3. PubMed ID: 6594976
    [Abstract] [Full Text] [Related]

  • 8. [Phase II study of a new nitrosourea derivative, MCNU, in tablet form. Takai Blood Cancer Study Group].
    Kobayashi T, Tanaka I, Shirakawa S, Fujiwara Y, Hirota Y, Kobayashi M, Ohno R, Yamada H, Mitomo Y, Yamamoto M.
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1079-85. PubMed ID: 3566304
    [Abstract] [Full Text] [Related]

  • 9. [Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
    Masaoka T, Kimura K, Miyazaki T, Sakurada K, Saitoh H, Morioka M, Fujimoto N, Musashi M, Wakui A, Yokoyama M, Kanamaru R, Oguro M, Takagi T, Konda C, Saitoh T, Nakao I, Harashima S, Ohhashi Y, Sakai Y, Sasaki T, Ohno R, Katoh Y, Yamada K, Hirota Y, Takada T, Hoshino A, Ohara K, Kamiya O, Kojima T, Nagata K, Nakamura T, Sasada M, Yonezawa T, Tsubakio T, Kanayama Y, Kitani T, Taniguchi N, Yasunaga K, Okamoto Y, Fujitake H, Ohkubo A, Horiuchi A, Tsubaki K, Takubo T, Shibata H, Kawagoe H, Hirata M, Matsubuchi T, Nagai K, Fujita S.
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1518-23. PubMed ID: 6347081
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S, Tashiro T, Ogawa M.
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Discriminant analysis of bone marrow suppression of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Saito A, Oride M, Munaka M, Uozumi T.
    Gan To Kagaku Ryoho; 1987 Feb; 14(2):511-5. PubMed ID: 3813579
    [Abstract] [Full Text] [Related]

  • 13. [Prolonged disappearance of the Ph1 chromosome in a case of chronic myelogenous leukemia after administration of MCNU].
    Kobayashi M, Sugiura I, Yamada K.
    Rinsho Ketsueki; 1987 Sep; 28(9):1640-4. PubMed ID: 3481407
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effectiveness of high-dose MCNU therapy and hematopoietic stem cell autografts treatment of childhood acute leukemia/lymphoma with high-risk features.
    Takaue Y, Watanabe T, Hoshi Y, Abe T, Matsunaga K, Saito S, Hirao A, Kawano Y, Ninomiya T, Kuroda Y.
    Cancer; 1991 Apr 01; 67(7):1830-7. PubMed ID: 1672260
    [Abstract] [Full Text] [Related]

  • 20. [Effect of MCNU on brain tumors. Part II: Clinical experience with MCNU on malignant brain tumors].
    Wakabayashi T, Yoshida J, Kito A, Inoue I, Kobayashi T, Kageyama N.
    Gan To Kagaku Ryoho; 1984 Dec 01; 11(12 Pt 2):2729-37. PubMed ID: 6095764
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.